Original Article
Shoulder-specific disability measures showed acceptable construct validity and responsiveness

https://doi.org/10.1016/j.jclinepi.2009.03.023Get rights and content

Abstract

Objective

To compare the construct validity and responsiveness of the Shoulder Pain and Disability Index (SPADI), Croft Index, and disabilities of the arm, shoulder, and hand (DASH) for patients with adhesive capsulitis and to compare these with pain on a visual analog scale, the Health Assessment Questionnaire, and the problem-elicitation technique.

Study Design and Setting

Two randomized double-blind placebo-controlled trials of interventions for adhesive capsulitis were performed. Both trials recruited patients from community-based physiotherapy practices. Responsiveness at 3 weeks postbaseline was assessed using four responsiveness parameters and three external criteria for improvement.

Results

Correlations between the shoulder-specific measures ranged from 0.55 to 0.65 at baseline and 0.49–0.55 for the 3-week change scores. Greater responsiveness was seen for the SPADI. The effect size for the SPADI ranged from 1.20 to 1.64, for the Croft Index from 0.87 to 1.21, and for the DASH from 0.55 to 0.83. Rankings were similar across the four responsiveness parameters and the three external criteria for improvement. Correlations between the shoulder-specific and generic measures for baseline and 3-week change scores were lower than those among the shoulder-specific measures (range: 0.17–0.60).

Conclusion

The shoulder-specific disability measures showed acceptable construct validity and responsiveness with a small but consistent overall advantage for the SPADI.

Introduction

What is new?

The key finding of this study

  1. The shoulder-specific disability measures (SPADI, Croft Index, and DASH) demonstrated adequate construct validity for patients with adhesive capsulitis.

  2. The pain visual analog score was the best performing generic measure in terms of responsiveness for this patient group.

  3. What this adds to what was known. The lower correlations between the PET score and other measures suggest that it may measure factors important to patients but not picked up with fixed-item questionnaires. The SPADI appeared to be preferable to the other fixed-item shoulder-specific indices but may perform differently in other patient populations and settings.

  4. What is the implication, what should change now. We recommend including at least one specific and one generic measure of outcome in clinical trials of shoulder disorders.

The shoulder-specific disability measures, namely Shoulder Pain and Disability Index (SPADI), Croft Index, and disabilities of the arm, shoulder, and hand (DASH), demonstrated adequate construct validity for patients with adhesive capsulitis. The lower correlations between the problem elicitation technique (PET) score and all the other measures suggest that the PET may measure factors important to patients but not picked up with fixed-item questionnaires. In terms of overall responsiveness, the SPADI performed better for most responsiveness indices than the Croft Index and the DASH.

The pain visual analog score was the best performing generic measure in terms of responsiveness for this patient group. The SPADI appeared to be preferable to the other fixed-item shoulder-specific indices but may perform differently in other patient populations and settings. We recommend including at least one specific and one generic measure of outcome in clinical trials of shoulder disorders.

Appropriate assessment of outcome is essential in determining the effectiveness of interventions in research and clinical practice. Pain, range of movement, and disability have been the most commonly used endpoints in clinical trials for shoulder disorders [1], [2], [3], [4], but choice of an assessment tool will be motivated by the psychometric properties of the instrument, such as reliability, construct validity, responsiveness, and ease of use. Michener and Leggin [5] compared 11 self-report shoulder-specific disability measures that had been assessed as reliable, valid, and responsive. All measures met minimum criteria and were judged to have adequate measurement properties but there was considerable variation between them.

In the context of a clinical trial, a responsive instrument should be able to distinguish differing treatment effects among interventions of differing efficacy, and highly responsive scales are preferred over lesser ones so that studies can be performed with fewer participants. The specific focus of shoulder-disability measures makes them potentially more responsive than arthritis-specific or generic health status measures for measuring shoulder disability. This has been demonstrated for the Shoulder Pain and Disability Index (SPADI) [6] in relation to the sickness impact profile [7] and to the Short Form-36 [8], but few studies have compared the responsiveness of different shoulder-specific disability measures [9], [10].

To study the responsiveness of an outcome measure, it is necessary to specify what constitutes improvement, to identify a group that shows improvement over time and to select the statistical indices for measuring responsiveness [11], [12], [13]. Different methods have been used [14] and prior studies have reported variable results by using different responsiveness indices [13], [14], [15].

The purpose of this study was to compare the construct validity and responsiveness of three fixed-item shoulder-specific disability indices: the SPADI [6], the Croft Index [16], and the DASH [17]. Three generic measures were included to allow for comparisons with the shoulder-specific measures: the problem-elicitation technique (PET), a patient preference disability questionnaire [18], [19]; overall pain intensity measured on a visual analog scale (VAS); and the arthritis-specific Health Assessment Questionnaire (HAQ) [20]. These measures were all used in two randomized double-blind placebo-controlled trials of interventions for adhesive capsulitis: arthrographic shoulder joint distension with saline and steroid [21] and short-course oral prednisolone [22].

We examined the robustness of the responsiveness estimates using four different responsiveness indices and three different external criteria for improvement. It was hypothesized that the shoulder-specific outcome measures would be highly correlated with each other and would have similar responsiveness for similar criteria of improvement. Correlation between the shoulder-specific and generic outcomes was expected to be lower because of the different focus of these questionnaires.

Section snippets

Methods

This analysis was based on data from two randomized double-blind placebo-controlled trials of interventions for patients with adhesive capsulitis. One trial investigated the efficacy of arthrographic joint distension [21]. The second investigated the efficacy of a short course of oral prednisolone [22]. Both trials showed a significant treatment effect at 3 weeks.

Detailed reports of the trials have been published elsewhere [21], [22]. Briefly, eligible participants for both trials were aged 18

Patient characteristics and responses

The baseline characteristics of the 95 patients (46 from the arthrographic joint distension trial and 49 from the oral prednisolone trial) are shown in Table 3. Over three-quarters of the patients were females and 10 had had symptoms for more than 1 year. After 3 weeks, 36 patients reported a marked improvement, 25 a moderate improvement, 17 no change, 13 a moderate worsening, and one patient reported a marked worsening.

At baseline, the mean score for the outcome measures, on a 1–100 scale, was

Discussion

The three shoulder-specific disability measures demonstrated adequate construct validity as indicated by their substantial or high baseline correlations. The lower correlations between the generic outcome measures suggest that these tools measure different aspects of the patient's pain, function, and disability. The PET score, in particular, may measure factors important to patients that are not picked up with fixed-item questionnaires. Correlations between the change scores at 3 weeks and

Acknowledgments

Jan Lucas Hoving and Henrica CW de Vet contributed to a preliminary draft of this report.

References (35)

  • S. Green et al.

    Interventions for shoulder pain

    Cochrane Database Syst Rev

    (2000)
  • R. Buchbinder et al.

    Arthrographic joint distension with saline and steroid improves function and reduces pain in patients with painful stiff shoulder: results of a randomised double-blind placebo-controlled trial

    Ann Rheum Dis

    (2004)
  • D.A. van der Windt et al.

    The responsiveness of the Shoulder Disability Questionnaire

    Ann Rheum Dis

    (1998)
  • J.W. Williams et al.

    Measuring shoulder function with the Shoulder Pain and Disability Index

    J Rheumatol

    (1995)
  • S.L. Heald et al.

    The shoulder pain and disability index: the construct validity and responsiveness of a region-specific disability measure

    Phys Ther

    (1997)
  • D.E. Beaton et al.

    Measuring function of the shoulder. A cross-sectional comparison of five questionnaires

    J Bone Joint Surg

    (1996)
  • M. Skutek et al.

    Outcome analysis following open rotator cuff repair. Early effectiveness validated using four different shoulder assessment scales

    Arch Orthop Trauma Surg

    (2000)
  • Cited by (58)

    • Cross-cultural adaptation, reliability, and validity of the Italian version of the Shoulder Disability Questionnaire

      2020, Musculoskeletal Science and Practice
      Citation Excerpt :

      Our study is the first assessing construct validity using an a-priori hypothesis testing approach, as the COSMIN initiative (Mokkink et al., 2010) suggests. Previous studies supported construct validity of the tool with high correlations noted between its original version with the DASH (rs = 0.65), the Visual Analogue Scale for pain (rs = 0.60) (Staples et al., 2009), as well as between the Korean version with the Shoulder Pain and Disability Index (rs = 0.72) and the NPRS (rs = 0.65) (Choi et al., 2015). This study presented several limitations to be discussed.

    • Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial

      2020, The Lancet
      Citation Excerpt :

      The primary endpoint was 12 months after randomisation. Secondary patient-reported outcome measures were the Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH)23 score, as a further region-specific measure of response to treatment;24 health-related quality of life using the 5-level version of the EuroQOL 5-Dimension questionnaire;25 the Numeric Rating Scale for pain;26 and the perceived extent of recovery measured by a single visual analogue scale (VAS) ranging from 0 (no need to seek further treatment) to 100 (definite need). The VAS for treatment recovery was purposefully designed for the study with input from patients and clinicians.

    View all citing articles on Scopus
    View full text